Neurology
Latest News
Migraine Drug Reduces Rosacea Flushing, Erythema in Small Study
In
Conference Coverage
Novel Agent Curbs Alzheimer’s-Related Agitation
More than half of participants in the open-label extension period of the randomized clinical trial responded to the medication, which was...
Conference Coverage
Tension, Other Headache Types Robustly Linked to Attempted, Completed Suicide
The results underscore the need for psychiatric evaluations in patients with a headache disorder.
Conference Coverage
In Lecanemab Alzheimer Extension Study, Placebo Roll-Over Group Does Not Catch Up
New data show little late benefit, but lecanemab is active when tau is low.
Latest News
Association Calls For Increased Oversight in Response to Reports of Possibly Counterfeit Botulinum Toxin
The ASDSA referenced investigations in Illinois and Tennessee in which suspected counterfeit neurotoxins were associated with individuals’...
Latest News
CDC Investigating Adverse Events Related to Counterfeit, Mishandled Botulinum Toxin
Reactions have included blurry vision, double vision, drooping eyelids, difficult swallowing or breathing, and other symptoms of botulism.
Latest News
Positive Results for Intranasal Oxytocin in Adults With Autism
Those receiving intranasal oxytocin showed clinical improvement on multiple mental health and quality of life measures.
Conference Coverage
Antidiabetic Drugs That Lower Stroke Risk Do So By Unclear Mechanisms
Some newer antidiabetic therapies provide protection against stroke even though their glycemic control is no better than the agents that have no...
Latest News
First US Adult ADHD Guidelines Finally on the Way?
ADHD is the second-most common psychiatric disorder in adults but mental health professionals report a lack of familiarity with the disorder in...
From the Journals
Delirium Linked to a Threefold Increased Risk for Dementia
The association, which increased with subsequent episodes of delirium, was strongest in men.
From the Journals
Chronic Pain Linked to Accelerated Brain Aging
The acceleration in brain aging was largely driven by the hippocampus and predicted memory decline and incident dementia during follow-up.